Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Seres Therapeutics (MCRB) over the last 8 years, with Q3 2025 value amounting to $53000.0.

  • Seres Therapeutics' Receivables - Other changed N/A to $53000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $53000.0, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is 6906.85% down from last year.
  • As of Q3 2025, Seres Therapeutics' Receivables - Other stood at $53000.0.
  • In the past 5 years, Seres Therapeutics' Receivables - Other registered a high of $125.0 million during Q1 2023, and its lowest value of $53000.0 during Q3 2025.
  • Over the past 3 years, Seres Therapeutics' median Receivables - Other value was $7.5 million (recorded in 2023), while the average stood at $18.9 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first soared by 14607.75% in 2024, then plummeted by 9850.01% in 2025.
  • Over the past 3 years, Seres Therapeutics' Receivables - Other (Quarter) stood at $8.7 million in 2023, then crashed by 69.07% to $2.7 million in 2024, then tumbled by 98.02% to $53000.0 in 2025.
  • Its last three reported values are $53000.0 in Q3 2025, $279000.0 for Q2 2025, and $1.6 million during Q1 2025.